This post is about Seracare’s new direction for Precision Medicine (in particular Precision Oncology), and the launch of a new product the Seraseq Solid Tumor Mutation Mix-I (AF20). But I’ll start first with a story from my days at Illumina. It was ten years ago this week that I last […]
Please consider subscribing to this blog - you'll be notified whenever new posts are published.
Your email address will not be shared or distributed. Thanks!